Literature DB >> 23348390

DKC1 gene mutations in human sporadic cancer.

Marianna Penzo1, Lucia Casoli, Claudio Ceccarelli, Davide Treré, Vienna Ludovini, Lucio Crinò, Lorenzo Montanaro.   

Abstract

INTRODUCTION: Germline mutations in the tumour suppressor gene dyskeratosis congenit 1 (DKC1) cause the cancer prone syndrome called X-linked dyskeratosis congenita. The present study aims to determine whether mutations of the DKC1 gene may also be present in frequent human sporadic cancers (breast, colon and lung cancers), thus potentially contributing to the neoplastic phenotype.
MATERIALS AND METHODS: mutation analysis of the DKC1 gene was performed on DNA from 110 primary human lung, 54 breast, and 35 colon cancers, focusing on gene regions where pathogenic germline mutations have been described previously (promoter and exons 1, 3, 9, 10, 11, and 14).
RESULTS: Out of a total of 199 primary tumours of different origins, only 5 turned out to have sequence variations in the DKC1 gene. These variations were of two kinds, C8120T and C13554T, which are both classified as synonymous mutations and do not affect DKC1 mRNA splicing.
CONCLUSION: direct DKC1 gene mutations are not a frequent event in tumourigenesis, at least in the tumour types investigated and for the DKC1 gene portions considered in this study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348390     DOI: 10.14670/HH-28.365

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

1.  RNA modifications and cancer.

Authors:  Phensinee Haruehanroengra; Ya Ying Zheng; Yubin Zhou; Yun Huang; Jia Sheng
Journal:  RNA Biol       Date:  2020-02-07       Impact factor: 4.652

2.  Silencing circular RNA-friend leukemia virus integration 1 restrained malignancy of CC cells and oxaliplatin resistance by disturbing dyskeratosis congenita 1.

Authors:  Weipeng Liu; Hong Jiang; Yuanqiang Li
Journal:  Open Life Sci       Date:  2022-05-18       Impact factor: 1.311

3.  Coordinated Regulation of UGT2B15 Expression by Long Noncoding RNA LINC00574 and hsa-miR-129-5p in HepaRG Cells.

Authors:  Dianke Yu; Jing Chen; Si Chen; Lin Xu; Leihong Wu; Dongying Li; Jiao Luo; Yuan Jin; Yanjie Zhao; Bridgett Knox; William H Tolleson; Xubing Wang; Lei Guo; Weida Tong; Baitang Ning
Journal:  Drug Metab Dispos       Date:  2020-02-21       Impact factor: 3.922

Review 4.  Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.

Authors:  Hanhan Shi; Peiwei Chai; Renbing Jia; Xianqun Fan
Journal:  Mol Cancer       Date:  2020-04-17       Impact factor: 27.401

5.  LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.

Authors:  Shi-Yuan Liu; Zhi-Yu Zhao; Zhe Qiao; Shao-Min Li; Wei-Ning Zhang
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 6.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities.

Authors:  Paz Nombela; Borja Miguel-López; Sandra Blanco
Journal:  Mol Cancer       Date:  2021-01-18       Impact factor: 27.401

7.  Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment.

Authors:  Jiahao Yu; Weirui Zhang; Dawei Ding; Yinan Hu; Guanya Guo; Jingbo Wang; Ying Han
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

8.  UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury.

Authors:  Xiaoyu Pan; Shuchun Chen; Xing Chen; Qingjuan Ren; Lin Yue; Shu Niu; Zelin Li; Ruiyi Zhu; Xiaoyi Chen; Zhuoya Jia; Ruoxi Zhen; Jiangli Ban
Journal:  J Diabetes Res       Date:  2022-06-13       Impact factor: 4.061

Review 9.  RNA Pseudouridylation in Physiology and Medicine: For Better and for Worse.

Authors:  Marianna Penzo; Ania N Guerrieri; Federico Zacchini; Davide Treré; Lorenzo Montanaro
Journal:  Genes (Basel)       Date:  2017-11-01       Impact factor: 4.096

Review 10.  Epitranscriptomics of cancer.

Authors:  Marina Tusup; Thomas Kundig; Steve Pascolo
Journal:  World J Clin Oncol       Date:  2018-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.